Antipodes Partners’s Procore PCOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$489K Sell
12,048
-466,698
-97% -$23.1M 0.01% 90
2026
Q1
$27.3M Sell
478,746
-379,065
-44% -$22.4M 0.53% 47
2025
Q4
$62.4M Buy
857,811
+6,856
+0.8% +$507K 1.31% 34
2025
Q3
$62.1M Buy
850,955
+653,174
+330% +$45.6M 1.39% 31
2025
Q2
$13.5M Buy
197,781
+98,847
+100% +$6.46M 0.42% 38
2025
Q1
$6.53M Buy
+98,934
New +$7.47M 0.2% 41

Other funds holding PCOR

Antipodes Partners's PCOR Position: Q2 2026 in Review

Antipodes Partners reduced its Procore (PCOR) stake by 97% in Q2 2026, selling an estimated $23.1M and leaving 12,048 shares worth $489K. The position accounts for 0.01% of the portfolio, ranked #90.

Antipodes Partners first reported a position in PCOR in Q1 2025 and has held it in 6 quarters since. The position peaked at $62.4M in Q4 2025. 399 funds tracked by Wall St. Rank hold PCOR as of Q2 2026.

  • Antipodes Partners held 12,048 shares of Procore worth $489K as of Q2 2026.
  • Antipodes Partners sold 466,698 Procore shares in Q2 2026, an estimated $23.1M.
  • Procore made up 0.01% of Antipodes Partners's portfolio in Q2 2026, its #90 holding.
  • Antipodes Partners first reported a position in Procore in Q1 2025 and has held it in 6 quarters since.
  • Antipodes Partners's Procore position peaked at $62.4M in Q4 2025.
  • 399 funds tracked by Wall St. Rank held Procore as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.